VOYA Investment Management
HBIO icon

VOYA Investment Management’s Harvard Bioscience HBIO Stock Holding History

VOYA Investment Management’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,451
Closed -$61.5K – 2867
2024
Q1 		$61.5K Sell
1,451
-266
-15% -$12K ﹤0.01% 2708
2023
Q4 		$91.8K Hold
1,717
– – ﹤0.01% 2776
2023
Q3 		$73.8K Buy
1,717
+113
+7% +$5.21K ﹤0.01% 2799
2023
Q2 		$88K Buy
+1,604
New +$88K ﹤0.01% 2824
2022
Q2 		– Sell
-2,254
Closed -$140K – 2820
2022
Q1 		$140K Buy
2,254
+654
+41% +$38.7K ﹤0.01% 2453
2021
Q4 		$113K Sell
1,600
-70
-4% -$4.98K ﹤0.01% 2653
2021
Q3 		$117K Hold
1,670
– – ﹤0.01% 2706
2021
Q2 		$139K Sell
1,670
-205
-11% -$14.5K ﹤0.01% 2693
2021
Q1 		$102K Hold
1,875
– – ﹤0.01% 2667
2020
Q4 		$80K Buy
1,875
+830
+79% +$31K ﹤0.01% 2598
2020
Q3 		$31K Buy
+1,045
New +$35.1K ﹤0.01% 2478
2019
Q2 		– Sell
-1,499
Closed -$65K – 2595
2019
Q1 		$65K Hold
1,499
– – ﹤0.01% 2491
2018
Q4 		$48K Hold
1,499
– – ﹤0.01% 2493
2018
Q3 		$79K Hold
1,499
– – ﹤0.01% 2528
2018
Q2 		$80K Buy
+1,499
New +$76.8K ﹤0.01% 2554

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

VOYA Investment Management's HBIO Position: Q2 2024 in Review

VOYA Investment Management sold out of Harvard Bioscience (HBIO) in Q2 2024, closing a stake of 1,451 shares — an estimated $61.5K sold.

VOYA Investment Management first reported a position in HBIO in Q2 2018 and held it in 15 quarters. The position peaked at $140K in Q1 2022. 100 funds tracked by Wall St. Rank hold HBIO as of Q2 2024.

  • VOYA Investment Management reported no remaining Harvard Bioscience position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,451 Harvard Bioscience shares in Q2 2024, an estimated $61.5K.
  • VOYA Investment Management first reported a position in Harvard Bioscience in Q2 2018 and held it in 15 quarters.
  • VOYA Investment Management's Harvard Bioscience position peaked at $140K in Q1 2022.
  • 100 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.